Gastrointestinal Cancer

Top Story

Bacteria film location, consistency differs in healthy, cancerous colons

August 18, 2017

As colon cancer rates increase in the U.S., researchers are looking to gut microbiota to find early predictors, such as bacterial biofilms found on the colon mucosa surface, according to a presentation at the NIH’s conference, “The Human Microbiome: Emerging Themes at the Horizon of the 21st Century.” In a recent study, signs pointed to increased and localized biofilm development in patients with colon cancer.

“By defining the microbial drivers of colon carcinogenesis, we can design new approaches to the prevention of human colon cancer,” Cynthia L. Sears, MD, from the Johns Hopkins School of Medicine, said in her presentation. “When diagnosed early, colorectal cancer — which is a leading cause of cancer death in men and women — is a completely preventable disease.”

Meeting News

Controlled feeding studies show promise for evaluating diet-gut microbiome interactions

August 18, 2017
Controlled feeding studies may help researchers better understand the effects of diet on the gut microbial structure in association with risk for disease, according to a…
In the Journals

Anal cancer survival rates lowest in black men

August 17, 2017
New research has identified significant racial and sex-based disparities in survival among patients with locoregional squamous cell carcinoma of the anus, especially in…

SillaJen, NCI enter agreement to evaluate Pexa-Vec for advanced colorectal cancer

August 17, 2017
SillaJen and NCI entered a cooperative research and development agreement to evaluate Pexa-Vec for the treatment of patients with advanced colorectal cancer. SillaJen…
More Headlines »
CME

The Patient with Castration-resistant Prostate Cancer

No commercial support for this activity.

Castration-resistant prostate cancer (CRPC) is a heterogeneous condition that encompasses a continuum of disease…
More »
Video
Meeting News Coverage

VIDEO: Studies address how to better use genetic testing

June 15, 2016
More »
Resource Centers

CME

The Patient with Severe Leukocytosis

No commercial support for this activity.

Currently five tyrosine kinase inhibitors are available for use in patients with chronic myeloid leukemia (CML)…
More »
Advertisement
Advertisement